Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.

Shares of Harrow, Inc. HROW fell sharply in today’s pre-market trading after posting weaker-than-expected fourth-quarter results.

Harrow Health posted adjusted loss of 20 cents per share, versus market estimates for a loss of 4 cents per share. The company’s quarterly sales came in at $36.35 million, missing expectations of $37.86 million, according to data from Benzinga Pro.

Harrow shares tumbled 14.6% to $9.09 in pre-market trading.

Here are some big stocks recording losses in today’s pre-market trading session.

  • Aquestive Therapeutics, Inc. AQST dipped 14.8% to $4.55 in pre-market trading. Aquestive Therapeutics priced its $75 million underwritten public offering of 16,666,667 common shares at $4.50 per share.
  • NuScale Power Corporation SMR shares dipped 6.8% to $6.13 in pre-market trading. NuScale Power shares dipped around 35% on Tuesday after Wells Fargo downgraded the stock from Equal-Weight to Underweight and lowered its price target from $7.50 to $4.50.
  • MaxCyte, Inc. MXCT shares fell 5.8% to $4.20 after gaining 7% on Tuesday. MaxCyte, last week, reported better-than-expected fourth-quarter financial results and issued FY24 guidance.
  • TeraWulf Inc. WULF shares declined 4.7% to $1.64 in pre-market trading following downbeat fourth-quarter results.
  • MicroStrategy Incorporated MSTR shares fell 3.9% to $1,362.64 in pre-market trading after declining over 5% on Wednesday. MicroStrategy completed $603.75 million offering of 0.875% convertible senior notes due 2031.
  • Nasdaq, Inc. NDAQ shares declined 3.1% to $60.52 in pre-market trading. Nasdaq priced secondary offering of 26,956,522 common shares by Borse Dubai at $59 per share.
  • Amcor plc AMCR shares fell 3% to $9.10 in pre-market trading after the company announced CEO transition and reaffirmed fiscal 2024 forecast.

 

Now Read This: Fear & Greed Index Remains In 'Greed' Zone Ahead Of Fed's Interest Rate Decision

Don’t forget to check out our premarket coverage here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading Ideasbig losersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!